Radiotherapy for Pancreatic Cancer
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Gastrointestinal Oncology".
Deadline for manuscript submissions: 31 August 2026 | Viewed by 5
Special Issue Editor
Special Issue Information
Dear Colleagues,
Pancreatic cancers are associated with poor survival and, although treatment approaches have evolved considerably in the last few years, the prognosis continues to be dismal. Since most patients present with advanced disease, and because the biology of these cancers is associated with early metastases, the treatment focus has mainly been on systemic therapies. That said, diagnosis and treatment in an early stage when the disease is localized is associated with a considerable improvement in survival and, while systemic treatments continue to be the cornerstone for management of pancreatic cancer, for localized and non-metastatic disease, local treatments including surgery and radiation may play a significant role in disease control and potentially even cure in some patients.
Radiotherapy has been evaluated as a treatment option both on its own as well as in conjunction with chemotherapy for the management of early-stage, borderline resectable and unresectable but non-metastatic disease, with reports showing varying outcomes. This Special Issue aims to present as much evidence as possible that specifically looks at the role of radiation in pancreatic cancers, especially in the era of advanced radiotherapy techniques|
I look forward to receiving your contributions.
Dr. Aswin Abraham
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pancreatic cancer
- radiation
- chemo-radiation
- SBRT
- patterns of failure
- radiobiology
- radiation techniques
- cell signaling
- immunotherapy and radiation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
